Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus (Q43758841)

26 November 2017

Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus (English)

1 reference

human subject research project

26 November 2017

0 references

author name string

Abu El-Asrar AM

1

1 reference

26 November 2017

Desmet S

2

1 reference

26 November 2017

Meersschaert A

3

1 reference

26 November 2017

Dralands L

4

1 reference

26 November 2017

Missotten L

5

1 reference

26 November 2017

Geboes K

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

American Journal of Ophthalmology

26 November 2017

1 reference

26 November 2017

132

1 reference

26 November 2017

551-556

1 reference

26 November 2017

4

1 reference

Nitric oxide as a secretory product of mammalian cells

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Inducible nitric oxide synthase: what difference does it make?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Inducible nitric oxide production and expression of transforming growth factor-beta1 in serum and CSF after cerebral ischaemic stroke in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Expression of inducible nitric oxide synthase immunoreactivity in rat brain following chronic hypoxia: effect of aminoguanidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase Cdelta activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor beta 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Aspects of the involvement of interleukin-1 and nitric oxide in the pathogenesis of insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Immunohistochemical characterization of retinal glial cell changes in areas of vascular occlusion secondary to diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Müller cell changes in human diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Induction and regulation of nitric oxide synthase in retinal Müller glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axotomized retinal ganglion cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Elevated vitreous nitric oxide levels in patients with proliferative diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Requirement for nitric oxide in retinal neuronal cell death induced by activated Müller glial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide mediates excitotoxic and anoxic damage in rat retinal ganglion cells cocultured with astroglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Nitric oxide neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Diabetes, advanced glycation endproducts and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Biological effects of aminoguanidine: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2801%2901127-8

10.1016/S0002-9394(01)01127-8

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference